Literature DB >> 26819522

Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.

Antonio Siniscalchi1, Lorenzo Gamberini1, Cristiana Laici1, Tommaso Bardi1, Giorgio Ercolani1, Laura Lorenzini1, Stefano Faenza1.   

Abstract

This review aims at evaluating the existing evidence regarding post reperfusion syndrome, providing a description of the pathophysiologic mechanisms involved and possible management and preventive strategies. A PubMed search was conducted using the MeSH database, "Reperfusion" AND "liver transplantation" were the combined MeSH headings; EMBASE and the Cochrane library were also searched using the same terms. 52 relevant studies and one ongoing trial were found. The concept of post reperfusion syndrome has evolved through years to a multisystemic disorder. The implications of the main organ, recipient and procedure related factors in the genesis of this complex syndrome are discussed in the text as the novel pharmacologic and technical approaches to reduce its incidence. However the available evidence about risk factors, physiopathology and preventive measures is still confusing, the presence of two main definitions and the numerosity of possible confounding factors greatly complicates the interpretation of the studies.

Entities:  

Keywords:  Drug therapy; Hemodynamics; Ischemia-reperfusion injury; Liver transplantation; Reperfusion

Mesh:

Year:  2016        PMID: 26819522      PMCID: PMC4721988          DOI: 10.3748/wjg.v22.i4.1551

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

1.  Influence of surgical technique on postreperfusion syndrome during liver transplantation.

Authors:  F Acosta; M A Rodriguez; T Sansano; R F Contreras; M Reche; V Roques; R Beltran; R Robles; F S Bueno; P Ramirez; P Parrilla
Journal:  Transplant Proc       Date:  1999-09       Impact factor: 1.066

2.  Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning.

Authors:  M R Schmidt; M Smerup; I E Konstantinov; M Shimizu; J Li; M Cheung; P A White; S B Kristiansen; K Sorensen; V Dzavik; A N Redington; R K Kharbanda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-12-15       Impact factor: 4.733

3.  Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation.

Authors:  J M Millis; J Melinek; M Csete; D K Imagawa; K M Olthoff; G Neelankanta; M Y Braunfeld; M J Sopher; S M Chan; J L Pregler; H Yersiz; A A Busuttil; C R Shackleton; A Shaked; R W Busuttil
Journal:  Transplantation       Date:  1997-02-15       Impact factor: 4.939

4.  Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation.

Authors:  I Garutti Martinez; L Olmedilla; J M Perez-Peña; M Zaballos; J Sanz; M D Vigil; J Navia
Journal:  Anesth Analg       Date:  1997-02       Impact factor: 5.108

5.  Remote ischemic perconditioning protects the liver from ischemia-reperfusion injury.

Authors:  Zoltán Czigány; Zsolt Turóczi; Péter Ónody; László Harsányi; Gábor Lotz; Viktor Hegedüs; Attila Szijártó
Journal:  J Surg Res       Date:  2013-07-31       Impact factor: 2.192

6.  Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center.

Authors:  A Nanashima; P Pillay; M Crawford; M Nakasuji; D J Verran; D Painter
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

7.  Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.

Authors:  A Dalmau; A Sabaté; F Acosta; L Garcia-Huete; M Koo; T Sansano; A Rafecas; J Figueras; E Jaurrieta; P Parrilla
Journal:  Anesth Analg       Date:  2000-07       Impact factor: 5.108

8.  Cardiac dysfunction during liver transplantation: incidence and preoperative predictors.

Authors:  Cristina Ripoll; María-Vega Catalina; Raquel Yotti; Luis Olmedilla; José Pérez-Peña; Oreste Lo Iacono; Diego Rincón; Miguel Angel García-Fernández; Javier Bermejo; Rafael Bañares
Journal:  Transplantation       Date:  2008-06-27       Impact factor: 4.939

9.  Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis.

Authors:  Cíntia Siqueira; Miguel Carneiro de Moura; Ana Julia Pedro; Paula Rocha
Journal:  World J Gastroenterol       Date:  2008-01-14       Impact factor: 5.742

10.  Aprotinin reduces vasoactive medication use during adult liver transplantation.

Authors:  James Y Findlay; Ronald P Kufner
Journal:  J Clin Anesth       Date:  2003-02       Impact factor: 9.452

View more
  27 in total

1.  Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.

Authors:  Hunter B Moore; Angelo D'Alessandro; Ernest E Moore; Matthew Wither; Peter J Lawson; Benjamin R Huebner; Kirk Hansen; Rashikh Choudhury; Trevor L Nydam
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

Review 2.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

3.  [Anesthesiological aspects of liver transplantation].

Authors:  S Dehne; F Lund; J Larmann; K Schmidt; T Brenner; M A Weigand; R von Haken
Journal:  Anaesthesist       Date:  2019-06       Impact factor: 1.041

4.  The Effect of Perioperative N-acetylcysteine on the Short and Long Term Outcomes in Pediatrics Undergoing Living-Donor Liver Transplantation.

Authors:  F Khalili; M B Khosravi; M A Sahmeddini; M H Eghbal; K Kazemi; S Nikeghbalian; S Ghazanfar Tehran; B Khosravi
Journal:  Int J Organ Transplant Med       Date:  2021

Review 5.  Renal Hemodynamics, Function, and Oxygenation in Critically Ill Patients and after Major Surgery.

Authors:  Sven-Erik Ricksten; Gudrun Bragadottir; Lukas Lannemyr; Bengt Redfors; Jenny Skytte
Journal:  Kidney360       Date:  2021-03-03

6.  Intra-Organ Delivery of Nanotherapeutics for Organ Transplantation.

Authors:  Bilal Hussain; Vivek Kasinath; Joren C Madsen; Jonathan Bromberg; Stefan G Tullius; Reza Abdi
Journal:  ACS Nano       Date:  2021-10-29       Impact factor: 18.027

7.  Impact of Different Embolic Agents for Transarterial Chemoembolization (TACE) Procedures on Systemic Vascular Endothelial Growth Factor (VEGF) Levels.

Authors:  Andreas Schicho; Claus Hellerbrand; Kristina Krüger; Lukas P Beyer; Walter Wohlgemuth; Christoph Niessen; Ernst Hohenstein; Christian Stroszczynski; Philippe L Pereira; Philipp Wiggermann
Journal:  J Clin Transl Hepatol       Date:  2016-12-27

Review 8.  Acute kidney injury and post-reperfusion syndrome in liver transplantation.

Authors:  Ilaria Umbro; Francesca Tinti; Irene Scalera; Felicity Evison; Bridget Gunson; Adnan Sharif; James Ferguson; Paolo Muiesan; Anna Paola Mitterhofer
Journal:  World J Gastroenterol       Date:  2016-11-14       Impact factor: 5.742

9.  Association Between Flushed Fluid Potassium Concentration and Severe Postreperfusion Syndrome in Deceased Donor Liver Transplantation.

Authors:  Liang Zhang; Ming Tian; Liying Sun; Zhijun Zhu
Journal:  Med Sci Monit       Date:  2017-10-29

10.  Renal function and oxygenation are impaired early after liver transplantation despite hyperdynamic systemic circulation.

Authors:  Jenny Skytte Larsson; Gudrun Bragadottir; Bengt Redfors; Sven-Erik Ricksten
Journal:  Crit Care       Date:  2017-04-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.